Everus Construction Group, Inc. ECG | NYSE

$45.32 $2.48 | 5.79%

Next Earnings: May 13, 2025

Company Overview:

Market Cap: $2.31B
PE Ratio: 16.13
52-Week Range: $31.38 - $77.93

0.5 Year Performance Metrics:

Total Return (with DRIP): -8.37% (-16.03% / yr)
Total Return (no DRIP): -8.37% (-16.03% / yr)
Share Price: -8.37%
ECG Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

ECG Earnings, Revenue, Cash & Debt, Shares Outstaning:

ECG - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
ECG - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ECG - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ECG - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
ECG - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
ECG - Cash & Debt
14-Day FREE Trial Get Full Access Now!
ECG - Revenue
14-Day FREE Trial Get Full Access Now!
ECG Revenue CAGR:1Y: 6.07%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
ECG EPS CAGR:1Y: 15.49%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Net Income
14-Day FREE Trial Get Full Access Now!
ECG Net Income CAGR:1Y: 15.97%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - EBITDA
14-Day FREE Trial Get Full Access Now!
ECG EBITDA CAGR:1Y: 6.78%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
ECG Free Cash Flow CAGR:1Y: -15.38%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
ECG Free Cash Flow / Share CAGR:1Y: -15.38%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Gross Profit
14-Day FREE Trial Get Full Access Now!
ECG Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Expenses
14-Day FREE Trial Get Full Access Now!
ECG Expenses CAGR:1Y: 129.36%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
ECG Shares Outstanding CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Share Buybacks
14-Day FREE Trial Get Full Access Now!
ECG Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
ECG Stock-Based Comp CAGR:1Y: 16.95%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ECG - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ECG Actual Revenue CAGR:1Y: 6.07%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ECG Actual EPS CAGR:1Y: 15.49%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ECG Actual Net Income CAGR:1Y: 15.97%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ECG Actual EBITDA CAGR:1Y: 6.78%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

ECG - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
ECG Net Profit Margin CAGR:1Y: 9.36%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
ECG Gross Profit Margin CAGR:1Y: -0.25%2Y: 0.00%5Y: 0.00%10Y: 0.00%
ECG - Price to Earnings
14-Day FREE Trial Get Full Access Now!
ECG - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
ECG - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
ECG - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for ECG

Based on past 0.5-year performance, here are ECG growth metrics:

Share price CAGR of -16.03%
Dividend CAGR of +0%

Using ECG CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ECG (DRIP)ECG - No DRIP
Current Price$44.90$44.90
Start Shares222.72222.72
Start Value$10,000$10,000
  
After 10 years:
Final Share Count222.72222.72
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$9.31$44.90
Total Dividends$0$0
Final Value$2,074$10,000

Estimated Future Value + Dividends - ECG

NOTE: Above numbers are our estimate based on ECG's Dividend and Price CAGR over past 0.5 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Everus Construction Group, Inc. (ECG) had its IPO on , and is trader on NYSE stock exchange.

ECG website: https://mducsg.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial